Sort
15,273 grants matching “antimicrobial resistance”
Defining high-risk genomic groups of Stenotrophomonas maltophilia
$481,214Yohei Doi · University Of Pittsburgh At Pittsburgh · R21 · FY2025 · AI
The Impact of Healthcare Exposure on Colonization with Antiseptic Tolerant Staphylococci in Children
$481,205Jonathon Chase McNeil · Baylor College Of Medicine · R01 · FY2021 · HS
Lung-resident antibacterial heterotypic immunity
$481,196Joseph P Mizgerd · Boston University Medical Campus · R01 · FY2021 · AI
Role of branched-chain fatty acids in physiology and virulence of Staphylococcus aureus
$481,130Shaun R Brinsmade · Georgetown University · R56 · FY2024 · AI
Durable Visible Light-activated Antivral Coatings for Fabrics Used for Personal P
$481,097Josef Stephan Schneider · Laamscience, Inc. · R44 · FY2010 · OH
Understanding and Informing Early Hospital Antibiotic Prescribing for Potential Infection
$480,904Hallie Christine Prescott · University Of Michigan At Ann Arbor · R01 · FY2021 · HS
Environmental hygiene strategies to decrease the burden of antibiotic-resistant organisms in Intensive Care Unit SINKs (ICU SINK)
$480,674Jennie H Kwon · Washington University · R01 · FY2022 · HS
Understanding in vivo antibiotic resistance in diverse Pseudomonas aeruginosa populations
$480,638Stephen Paul Diggle · Georgia Institute Of Technology · R01 · FY2022 · AI
Survival of Neisseria gonorrhoeae after primary human neutrophil challenge
$480,638Alison K Criss · University Of Virginia · R01 · FY2014 · AI
Understanding in vivo antibiotic resistance in diverse Pseudomonas aeruginosa populations
$480,638Stephen Paul Diggle · Georgia Institute Of Technology · R01 · FY2024 · AI
Understanding in vivo antibiotic resistance in diverse Pseudomonas aeruginosa populations
$480,638Stephen Paul Diggle · Georgia Institute Of Technology · R01 · FY2025 · AI
Understanding in vivo antibiotic resistance in diverse Pseudomonas aeruginosa populations
$480,638Stephen Paul Diggle · Georgia Institute Of Technology · R01 · FY2023 · AI
Development of SecA as an Antimicrobial Target
$480,478Cubist Pharmaceuticals, Inc. · R44 · FY2001 · AI
Integration of heme acquisition and signaling in Gram-negative pathogens
$480,452Angela None Wilks · University Of Maryland Baltimore · R01 · FY2024 · AI
Integration of heme acquisition and signaling in Gram-negative pathogens
$480,452Angela None Wilks · University Of Maryland Baltimore · R01 · FY2025 · AI
Integration of heme acquisition and signaling in Gram-negative pathogens
$480,452Angela None Wilks · University Of Maryland Baltimore · R01 · FY2023 · AI
COBRE Center for Antimicrobial Resistance and Therapeutic Discovery - Administrative Core
$480,333Eleftherios Mylonakis · Miriam Hospital · P20 · FY2019 · GM
A Trial to Explore the Benefits of Antimicrobial Self-Sanitizing Surfaces on Bio-Burden Levels and Healthcare-Acquired Infections.
$480,279Chetan Jinadatha · Central Texas Veterans Research Foundation · R01 · FY2020 · HS
Ribosome Structure and Function
$480,266Harry F Noller · University Of California Santa Cruz · R01 · FY2008 · GM
Novel antibiotics that trap Holliday junctions
$480,263San Diego State University · R01 · FY2004 · AI
Containing Bioterroist and Emerging Infectious Diseases
$480,226Ira M Longini · Fred Hutchinson Cancer Research Center · U01 · FY2007 · GM
Immunology And Pathology Of Acute and Chronic Murine Leukemia Virus Infections
$480,128Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Role of Selected Major and Minor Alloy Alloying Elements in Copper Alloys on Copper Ion Release and Oxide Formation for Anti-Microbial Functionality
$480,000John R Scully · University Of Virginia Main Campus · · FY2013 · MPS
Chromsome Modification and Transcription Repression in Regulation of Systemic Acquired Resistance
$480,000Xinnian Dong · Duke University · · FY2005 · BIO
Project 2: Leveraging Metagenomics of the Microbiome to predict colonization/infection by antimicrobial-resistant pathogens
$480,000Samuel A Shelburne · University Of Texas Hlth Sci Ctr Houston · P01 · FY2021 · AI